Search results
Results From The WOW.Com Content Network
In February 2015, Labcorp acquired Covance for $6.1 billion in cash and stock. [37] [38] In 2016, the company entered into a strategic alliance with Global Specimen Solutions, in which the company offered GSS products GlobalCODE and snapTRACK to its clients. [39] In December 2017, Covance acquired the company. [40]
In December 2014, Labcorp acquired Bode Technology Group, a provider of forensic DNA analysis, DNA collection products, and relationship testing and the largest DNA forensic testing company in the U.S., from SolutionPoint International. [49] [50] [51] In February 2015, Labcorp acquired Covance for $6.1 billion. [52] [53]
The companies are discussing a deal in which part of LabCorp's Covance clinical research division would merge with Syneos. The sources said that the companies are discussing structuring the deal ...
April 1999: Covance (now Fortea) announced it would acquire Parexel for $612.7 million in stock; [20] however, the agreement was terminated two months later. [21] September 1999: Parexel acquires CEMAF S.A., a Phase I clinical research and bioanalytical laboratory located in Poitiers, France for an initial cash payment of approximately $3.0 ...
LabCorp's (LH) Covance arm grows on strategic acquisitions including MI Bioresearch. Skip to main content. Sign in. Mail. 24/7 Help. For premium support please call: 800-290-4726 more ...
Within Covance Drug Development, LabCorp (LH) is expected to drive profitable growth through expanded solutions and enhanced operational capabilities.
Syneos Health (formerly InVentiv Health Incorporated and INC Research) is an American company that provides contract research and commercial services to pharmaceutical and biotechnology companies. Based in Morrisville, North Carolina , the company specializes in helping other companies with late-stage clinical trials, but also provides ...
For premium support please call: 800-290-4726 more ways to reach us